Issues related to drug pricing and reimbursement for prescription drugs; Issues affecting the pharmaceutical industry; Issues related to orphan drugs; Issues related to Medicare Part B and Medicare Part D drug pricing.
2025 · 2nd Quarter (Apr 1 - June 30)
TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.
Filed by B HALL STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Jul 15, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- B HALL STRATEGIES, LLC
- Filing UUID
- cb454c19-8bdd-46cd-8859-2fc4e7fc732c
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to drug pricing and reimbursement for prescription drugs; Issues affecting the pharmaceutical industry; Issues related to orphan drugs; Issues related to Medicare Part B and Medicare Part D drug pricing.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.